Role of microRNA-30c targeting ADAM19 in colorectal cancer

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Zhang, Qian ^a,b   Yu, Lei ^a,b   Qin, Dandan ^a   Huang, Rui ^a,b   Jiang, Xiaochen ^b   Zou, Chendan ^b   Tang, Qingchao ^a,b   Chen, Yinggang ^a,b   Wang, Guiyu ^a,b   Wang, Xishan ^a,b   Gao, Xu ^b  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM19 PROTEIN; METALLOPROTEINASE; MICRORNA; MICRORNA 30C; UNCLASSIFIED DRUG; ADAM PROTEIN; ADAM19 PROTEIN, HUMAN; MIRN30 MICRORNA, HUMAN;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL LINE; CANCER GROWTH; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; EMBRYO; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; TUMOR XENOGRAFT; ANIMAL; BINDING SITE; CANCER GRADING; CANCER STAGING; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; COLORECTAL TUMOR; DISEASE MODEL; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; REPORTER GENE; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR VOLUME; VERY ELDERLY;

ADAM PROTEINS; AGED; AGED, 80 AND OVER; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; MALE; MICE; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; RNA INTERFERENCE; TRANSFECTION; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84925725829     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120698     Document Type: Article

References (42)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116: 281-297. PMID: 14744438
2. Jurmeister S, Baumann M, Balwierz A, Keklikoglou I, Ward A, Uhlmann S, et al. MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F. Mol Cell Biol. 2012; 32: 633-651. doi: 10.1128/MCB.06212-11 PMID: 22144583
3. Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A. 2008; 105: 13421-13426. doi: 10.1073/pnas.0801613105 PMID: 18755897
4. Michael MZ, SM OC, van Holst Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res. 2003; 1: 882-891. PMID: 14573789
5. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004; 101: 2999-3004. PMID: 14973191
6. Cheng CW, Wang HW, Chang CW, Chu HW, Chen CY, Yu JC, et al. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. Breast Cancer Res Treat. 2012; 134: 1081-1093. doi: 10.1007/s10549-012-2034-4 PMID: 22476851
7. Leung YK, Chan QK, Ng CF, Ma FM, Tse HM, To KF, et al. Hsa-miRNA-765 as a key mediator for inhibiting growth, migration and invasion in fulvestrant-treated prostate cancer. PLoS One. 2014; 9: e98037. doi: 10.1371/journal.pone.0098037 PMID: 24837491
8. Kong X, Xu X, Yan Y, Guo F, Li J, Hu Y, et al. Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer. PLoS One. 2014; 9: e90810. doi: 10.1371/journal.pone.0090810 PMID: 24595016
9. Yamakuchi M, Lotterman CD, Bao C, Hruban RH, Karim B, Mendell JT, et al. P53-induced microRNA- 107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci U S A. 2010; 107: 6334-6339. doi: 10.1073/pnas.0911082107 PMID: 20308559
10. Fernandez S, Risolino M, Mandia N, Talotta F, Soini Y, Incoronato M, et al. miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer. Oncogene. 2014; 0:
11. Chan SH, Huang WC, Chang JW, Chang KJ, Kuo WH, Wang MY, et al. MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis. Oncogene. 2014; 33: 4496-4507. doi: 10.1038/onc.2014.10 PMID: 24608434
12. Wang Y, Tang Q, Li M, Jiang S, Wang X. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA. Biochem Biophys Res Commun. 2014; 444: 199-204. doi: 10.1016/j.bbrc.2014.01.028 PMID: 24440701
13. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2013; 63: 11-30. doi: 10.3322/caac.21166 PMID: 23335087
14. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2008; 40: 43-50. PMID: 18066065
15. Rodriguez-Gonzalez FG, Sieuwerts AM, Smid M, Look MP, Meijer-van Gelder ME, de Weerd V, et al. MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer. Breast Cancer Res Treat. 2011; 127: 43-51. doi: 10.1007/s10549-010-0940-x PMID: 20490652
16. Wu F, Zhu S, Ding Y, Beck WT, Mo YY. MicroRNA-mediated regulation of Ubc9 expression in cancer cells. Clin Cancer Res. 2009; 15: 1550-1557. doi: 10.1158/1078-0432.CCR-08-0820 PMID: 19223510
17. Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, et al. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology. 2008; 47: 897-907. doi: 10.1002/hep.22160 PMID: 18176954
18. Li Q, Zou C, Zou C, Han Z, Xiao H, Wei H, et al. MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7. Cancer Lett. 2013; 335: 168-174. doi: 10.1016/j.canlet.2013.02.029 PMID: 23435373
19. Zhong K, Chen K, Han L, Li B. microRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18. BMC Cancer. 2014; 14: 703. doi: 10.1186/1471-2407-14-703 PMID: 25249344
20. Ling XH, Han ZD, Xia D, He HC, Jiang FN, Lin ZY, et al. MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancer. Mol Biol Rep. 2014; 41: 2779-2788. doi: 10.1007/s11033-014-3132-7 PMID: 24452717
21. Fuster O, Llop M, Dolz S, Garcia P, Such E, Ibanez M, et al. Adverse prognostic value of MYBL2 overexpression and association with microRNA-30 family in acute myeloid leukemia patients. Leuk Res. 2013; 37: 1690-1696. doi: 10.1016/j.leukres.2013.09.015 PMID: 24199710
22. Li S, Yang C, Zhai L, Zhang W, Yu J, Gu F, et al. Deep sequencing reveals small RNA characterization of invasive micropapillary carcinomas of the breast. Breast Cancer Res Treat. 2012; 136: 77-87. doi: 10.1007/s10549-012-2166-6 PMID: 22976804
23. Dobson JR, Taipaleenmaki H, Hu YJ, Hong D, van Wijnen AJ, Stein JL, et al. hsa-mir-30c promotes the invasive phenotype of metastatic breast cancer cells by targeting NOV/CCN3. Cancer Cell Int. 2014; 14: 73. doi: 10.1186/s12935-014-0073-0 PMID: 25120384
24. Huang J, Yao X, Zhang J, Dong B, Chen Q, Xue W, et al. Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma. Cancer Sci. 2013; 104: 1609-1617. doi: 10.1111/cas.12291 PMID: 24112779
25. Seals DF, Courtneidge SA. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 2003; 17: 7-30. PMID: 12514095
26. Mochizuki S, Okada Y. ADAMs in cancer cell proliferation and progression. Cancer Sci. 2007; 98: 621-628. PMID: 17355265
27. Zhou HM, Weskamp G, Chesneau V, Sahin U, Vortkamp A, Horiuchi K, et al. Essential role for ADAM19 in cardiovascular morphogenesis. Mol Cell Biol. 2004; 24: 96-104. PMID: 14673146
28. Wang HX, Zhao YG, Wang HM, Yang Q, Lin HY, Sang QX, et al. Expression of adamalysin 19/ADAM19 in the endometrium and placenta of rhesus monkey (Macaca mulatta) during early pregnancy. Mol Hum Reprod. 2005; 11: 429-435. PMID: 15901844
29. Wildeboer D, Naus S, Amy Sang QX, Bartsch JW, Pagenstecher A. Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness. J Neuropathol Exp Neurol. 2006; 65: 516-527. PMID: 16772875
30. Roemer A, Schwettmann L, Jung M, Roigas J, Kristiansen G, Schnorr D, et al. Increased mRNA expression of ADAMs in renal cell carcinoma and their association with clinical outcome. Oncol Rep. 2004; 11: 529-536. PMID: 14719095
31. Ramdas V, McBride M, Denby L, Baker AH. Canonical transforming growth factor-beta signaling regulates disintegrin metalloprotease expression in experimental renal fibrosis via miR-29. Am J Pathol. 2013; 183: 1885-1896. doi: 10.1016/j.ajpath.2013.08.027 PMID: 24103556
32. Kumarswamy R, Mudduluru G, Ceppi P, Muppala S, Kozlowski M, Niklinski J, et al. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer. Int J Cancer. 2012; 130: 2044-2053. doi: 10.1002/ijc.26218 PMID: 21633953
33. Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A, et al. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene. 2007; 26: 7590-7595. PMID: 17563749
34. Li X, Zhang Y, Zhang Y, Ding J, Wu K, Fan D. Survival prediction of gastric cancer by a seven-micro- RNA signature. Gut. 2010; 59: 579-585. doi: 10.1136/gut.2008.175497 PMID: 19951901
35. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD, et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A. 2004; 101: 11755-11760. PMID: 15284443
36. Quintavalle C, Donnarumma E, Iaboni M, Roscigno G, Garofalo M, Romano G, et al. Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells. Oncogene. 2013; 32: 4001-4008. doi: 10.1038/onc.2012.410 PMID: 22964638
37. Ichikawa T, Sato F, Terasawa K, Tsuchiya S, Toi M, Tsujimoto G, et al. Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells. PLoS One. 2012; 7: e31422. doi: 10.1371/journal.pone.0031422 PMID: 22384020
38. Yao J, Liang L, Huang S, Ding J, Tan N, Zhao Y, et al. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology. 2010; 51: 846-856. doi: 10.1002/hep.23443 PMID: 20054866
39. Gaziel-Sovran A, Segura MF, Di Micco R, Collins MK, Hanniford D, Vega-Saenz de Miera E, et al. miR- 30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell. 2011; 20: 104-118. doi: 10.1016/j.ccr.2011.05.027 PMID: 21741600
40. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, et al. Serum microRNA signatures identified in a genomewide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol. 2010; 28: 1721-1726. doi: 10.1200/JCO.2009.24.9342 PMID: 20194856
41. Li N, Kaur S, Greshock J, Lassus H, Zhong X, Wang Y, et al. A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer. Cancer Res. 2012; 72: 154-164. doi: 10.1158/0008-5472.CAN-11-2484 PMID: 22058146
42. Liu N, Chen NY, Cui RX, Li WF, Li Y, Wei RR, et al. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol. 2012; 13: 633-641. doi: 10.1016/S1470-2045(12)70102-X PMID: 22560814